LGVN
Longeveron Powers Ahead: Revolutionary Stem Cell Therapy Poised for Transformative Milestones
As a leader in the stem cell therapy space, Longeveron is poised to make significant strides in its four development programs, potentially redefining the trajectory of the company. In its recently concluded Q2 2026 financial results and business update conference call, the company highlighted several key highlights from the quarter,